drugset

drugset / Trial / NCT00386750

Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function

NCT00386750 ↗

Phase 4 Terminated 265 enrolled Novartis Pharmaceuticals

RandomizedParallel-groupOpen-labelTreatment

Summary

THIS STUDY IS NOT ENROLLING PATIENTS IN THE USA. To evaluate the effects of artemether/ lumefantrine on the auditory function.

Timeline

Start: 2005-06
Primary completion: 2005-11
Completion: 2005-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Artemether-lumefantrine	Unknown	—	—

Indications